Selected research
Market Structure
Global Non-lethal Biochemical Weapons Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Non-lethal Biochemical Weapons market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Non-lethal Biochemical Weapons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Non-lethal Biochemical Weapons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Non-lethal Biochemical Weapons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Non-lethal Biochemical Weapons is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Non-lethal Biochemical Weapons include Lamperd Less Lethal, BAE Systems, Inc., QinetiqGroup, Inc., General Dynamics Corporation, TASER International,Inc., Moog, Inc., Raytheon Company, Chemring Group PLC. and Textron Systems, Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Non-lethal Biochemical Weapons output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Non-lethal Biochemical Weapons by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Non-lethal Biochemical Weapons market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Non-lethal Biochemical Weapons and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Non-lethal Biochemical Weapons sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-lethal Biochemical Weapons market size, projected growth trends, production technologies, key applications, and end-use industries.
Non-lethal Biochemical Weapons Segment by Company
Lamperd Less Lethal
BAE Systems, Inc.
QinetiqGroup, Inc.
General Dynamics Corporation
TASER International,Inc.
Moog, Inc.
Raytheon Company
Chemring Group PLC.
Textron Systems, Corp
LRAD Corporation
Non-lethal Biochemical Weapons Segment by Type
Directed Energy
Direct Contact
Non-lethal Biochemical Weapons Segment by Application
Military Forces
Law Enforcement Agencies
Non-lethal Biochemical Weapons Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-lethal Biochemical Weapons market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-lethal Biochemical Weapons and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-lethal Biochemical Weapons.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Non-lethal Biochemical Weapons market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-lethal Biochemical Weapons industry.
Chapter 3: Detailed analysis of Non-lethal Biochemical Weapons market competition landscape. Including Non-lethal Biochemical Weapons manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Non-lethal Biochemical Weapons by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Non-lethal Biochemical Weapons in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Directed Energy
- Direct Contact
Applications
- Military Forces
- Law Enforcement Agencies
Companies covered
- Lamperd Less Lethal
- BAE Systems, Inc.
- QinetiqGroup, Inc.
- General Dynamics Corporation
- TASER International,Inc.
- Moog, Inc.
- Raytheon Company
- Chemring Group PLC.
- Textron Systems, Corp
- LRAD Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Non-lethal Biochemical Weapons Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Non-lethal Biochemical Weapons Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Non-lethal Biochemical Weapons Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Non-lethal Biochemical Weapons Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Non-lethal Biochemical Weapons Market Dynamics
- 2.1 Non-lethal Biochemical Weapons Industry Trends
- 2.2 Non-lethal Biochemical Weapons Industry Drivers
- 2.3 Non-lethal Biochemical Weapons Industry Opportunities and Challenges
- 2.4 Non-lethal Biochemical Weapons Industry Restraints
3 Non-lethal Biochemical Weapons Market by Manufacturers
- 3.1 Global Non-lethal Biochemical Weapons Production Value by Manufacturers (2021-2026)
- 3.2 Global Non-lethal Biochemical Weapons Production by Manufacturers (2021-2026)
- 3.3 Global Non-lethal Biochemical Weapons Average Price by Manufacturers (2021-2026)
- 3.4 Global Non-lethal Biochemical Weapons Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Non-lethal Biochemical Weapons Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Non-lethal Biochemical Weapons Manufacturers, Product Type & Application
- 3.7 Global Non-lethal Biochemical Weapons Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Non-lethal Biochemical Weapons Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Non-lethal Biochemical Weapons Players Market Share by Production Value in 2025
- 3.8.3 2025 Non-lethal Biochemical Weapons Tier 1, Tier 2, and Tier 3
4 Non-lethal Biochemical Weapons Market by Type
- 4.1 Non-lethal Biochemical Weapons Type Introduction
- 4.1.1 Directed Energy
- 4.1.2 Direct Contact
- 4.2 Global Non-lethal Biochemical Weapons Production by Type
- 4.2.1 Global Non-lethal Biochemical Weapons Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Non-lethal Biochemical Weapons Production by Type (2021-2032)
- 4.2.3 Global Non-lethal Biochemical Weapons Production Market Share by Type (2021-2032)
- 4.3 Global Non-lethal Biochemical Weapons Production Value by Type
- 4.3.1 Global Non-lethal Biochemical Weapons Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Non-lethal Biochemical Weapons Production Value by Type (2021-2032)
- 4.3.3 Global Non-lethal Biochemical Weapons Production Value Market Share by Type (2021-2032)
5 Non-lethal Biochemical Weapons Market by Application
- 5.1 Non-lethal Biochemical Weapons Application Introduction
- 5.1.1 Military Forces
- 5.1.2 Law Enforcement Agencies
- 5.2 Global Non-lethal Biochemical Weapons Production by Application
- 5.2.1 Global Non-lethal Biochemical Weapons Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Non-lethal Biochemical Weapons Production by Application (2021-2032)
- 5.2.3 Global Non-lethal Biochemical Weapons Production Market Share by Application (2021-2032)
- 5.3 Global Non-lethal Biochemical Weapons Production Value by Application
- 5.3.1 Global Non-lethal Biochemical Weapons Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Non-lethal Biochemical Weapons Production Value by Application (2021-2032)
- 5.3.3 Global Non-lethal Biochemical Weapons Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Lamperd Less Lethal
- 6.1.1 Lamperd Less Lethal Company Information
- 6.1.2 Lamperd Less Lethal Business Overview
- 6.1.3 Lamperd Less Lethal Non-lethal Biochemical Weapons Production, Value and Gross Margin (2021-2026)
- 6.1.4 Lamperd Less Lethal Non-lethal Biochemical Weapons Product Portfolio
- 6.1.5 Lamperd Less Lethal Recent Developments
- 6.2 BAE Systems, Inc.
- 6.2.1 BAE Systems, Inc. Company Information
- 6.2.2 BAE Systems, Inc. Business Overview
- 6.2.3 BAE Systems, Inc. Non-lethal Biochemical Weapons Production, Value and Gross Margin (2021-2026)
- 6.2.4 BAE Systems, Inc. Non-lethal Biochemical Weapons Product Portfolio
- 6.2.5 BAE Systems, Inc. Recent Developments
- 6.3 QinetiqGroup, Inc.
- 6.3.1 QinetiqGroup, Inc. Company Information
- 6.3.2 QinetiqGroup, Inc. Business Overview
- 6.3.3 QinetiqGroup, Inc. Non-lethal Biochemical Weapons Production, Value and Gross Margin (2021-2026)
- 6.3.4 QinetiqGroup, Inc. Non-lethal Biochemical Weapons Product Portfolio
- 6.3.5 QinetiqGroup, Inc. Recent Developments
- 6.4 General Dynamics Corporation
- 6.4.1 General Dynamics Corporation Company Information
- 6.4.2 General Dynamics Corporation Business Overview
- 6.4.3 General Dynamics Corporation Non-lethal Biochemical Weapons Production, Value and Gross Margin (2021-2026)
- 6.4.4 General Dynamics Corporation Non-lethal Biochemical Weapons Product Portfolio
- 6.4.5 General Dynamics Corporation Recent Developments
- 6.5 TASER International,Inc.
- 6.5.1 TASER International,Inc. Company Information
- 6.5.2 TASER International,Inc. Business Overview
- 6.5.3 TASER International,Inc. Non-lethal Biochemical Weapons Production, Value and Gross Margin (2021-2026)
- 6.5.4 TASER International,Inc. Non-lethal Biochemical Weapons Product Portfolio
- 6.5.5 TASER International,Inc. Recent Developments
- 6.6 Moog, Inc.
- 6.6.1 Moog, Inc. Company Information
- 6.6.2 Moog, Inc. Business Overview
- 6.6.3 Moog, Inc. Non-lethal Biochemical Weapons Production, Value and Gross Margin (2021-2026)
- 6.6.4 Moog, Inc. Non-lethal Biochemical Weapons Product Portfolio
- 6.6.5 Moog, Inc. Recent Developments
- 6.7 Raytheon Company
- 6.7.1 Raytheon Company Company Information
- 6.7.2 Raytheon Company Business Overview
- 6.7.3 Raytheon Company Non-lethal Biochemical Weapons Production, Value and Gross Margin (2021-2026)
- 6.7.4 Raytheon Company Non-lethal Biochemical Weapons Product Portfolio
- 6.7.5 Raytheon Company Recent Developments
- 6.8 Chemring Group PLC.
- 6.8.1 Chemring Group PLC. Company Information
- 6.8.2 Chemring Group PLC. Business Overview
- 6.8.3 Chemring Group PLC. Non-lethal Biochemical Weapons Production, Value and Gross Margin (2021-2026)
- 6.8.4 Chemring Group PLC. Non-lethal Biochemical Weapons Product Portfolio
- 6.8.5 Chemring Group PLC. Recent Developments
- 6.9 Textron Systems, Corp
- 6.9.1 Textron Systems, Corp Company Information
- 6.9.2 Textron Systems, Corp Business Overview
- 6.9.3 Textron Systems, Corp Non-lethal Biochemical Weapons Production, Value and Gross Margin (2021-2026)
- 6.9.4 Textron Systems, Corp Non-lethal Biochemical Weapons Product Portfolio
- 6.9.5 Textron Systems, Corp Recent Developments
- 6.10 LRAD Corporation
- 6.10.1 LRAD Corporation Company Information
- 6.10.2 LRAD Corporation Business Overview
- 6.10.3 LRAD Corporation Non-lethal Biochemical Weapons Production, Value and Gross Margin (2021-2026)
- 6.10.4 LRAD Corporation Non-lethal Biochemical Weapons Product Portfolio
- 6.10.5 LRAD Corporation Recent Developments
7 Global Non-lethal Biochemical Weapons Production by Region
- 7.1 Global Non-lethal Biochemical Weapons Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Non-lethal Biochemical Weapons Production by Region (2021-2032)
- 7.2.1 Global Non-lethal Biochemical Weapons Production by Region (2021-2026)
- 7.2.2 Global Non-lethal Biochemical Weapons Production Forecast by Region (2027-2032)
- 7.3 Global Non-lethal Biochemical Weapons Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Non-lethal Biochemical Weapons Production Value by Region (2021-2032)
- 7.4.1 Global Non-lethal Biochemical Weapons Production Value by Region (2021-2026)
- 7.4.2 Global Non-lethal Biochemical Weapons Production Value by Region (2027-2032)
- 7.5 Global Non-lethal Biochemical Weapons Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Non-lethal Biochemical Weapons Production Value (2021-2032)
- 7.6.2 Europe Non-lethal Biochemical Weapons Production Value (2021-2032)
- 7.6.3 Asia-Pacific Non-lethal Biochemical Weapons Production Value (2021-2032)
- 7.6.4 South America Non-lethal Biochemical Weapons Production Value (2021-2032)
- 7.6.5 Middle East & Africa Non-lethal Biochemical Weapons Production Value (2021-2032)
8 Global Non-lethal Biochemical Weapons Consumption by Region
- 8.1 Global Non-lethal Biochemical Weapons Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Non-lethal Biochemical Weapons Consumption by Region (2021-2032)
- 8.2.1 Global Non-lethal Biochemical Weapons Consumption by Region (2021-2026)
- 8.2.2 Global Non-lethal Biochemical Weapons Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Non-lethal Biochemical Weapons Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Non-lethal Biochemical Weapons Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Non-lethal Biochemical Weapons Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Non-lethal Biochemical Weapons Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Non-lethal Biochemical Weapons Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Non-lethal Biochemical Weapons Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Non-lethal Biochemical Weapons Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Non-lethal Biochemical Weapons Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Non-lethal Biochemical Weapons Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Non-lethal Biochemical Weapons Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Non-lethal Biochemical Weapons Value Chain Analysis
- 9.1.1 Non-lethal Biochemical Weapons Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Non-lethal Biochemical Weapons Production Mode & Process
- 9.2 Non-lethal Biochemical Weapons Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Non-lethal Biochemical Weapons Distributors
- 9.2.3 Non-lethal Biochemical Weapons Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst